Datasheet

Product name: DOWSIL™ 1200 OS Primer Clear
Revision Date: 22.08.2018
Version: 1.0
Page 3 of 16
CASRN
18765-38-3
EC-No.
242-560-0
Index-No.
–
_
>= 5,0 - <= 6,0 %
Tetrakis(2-
butoxyethyl)
orthosilicate
Skin Irrit. - 2 - H315
CASRN
5593-70-4
EC-No.
227-006-8
Index-No.
–
01-2119967423-33
>= 4,0 - <= 5,0 %
Tetra n-Butyl
titanate
Flam. Liq. - 3 - H226
Skin Irrit. - 2 - H315
Eye Dam. - 1 - H318
STOT SE - 3 - H336
STOT SE - 3 - H335
Substances with a workplace exposure limit
CASRN
107-51-7
EC-No.
203-497-4
Index-No.
–
01-2119970219-31
>= 83,0 - <= 87,0 %
Octamethyltrisiloxa
ne
Flam. Liq. - 3 - H226
For the full text of the H-Statements mentioned in this Section, see Section 16.
SECTION 4: FIRST AID MEASURES
4.1 Description of first aid measures
General advice:
First Aid responders should pay attention to self-protection and use the recommended protective
clothing (chemical resistant gloves, splash protection). If potential for exposure exists refer to Section
8 for specific personal protective equipment.
Inhalation: Move person to fresh air; if effects occur, consult a physician.
Skin contact: Wash off with plenty of water. Suitable emergency safety shower facility should be
available in work area.
Eye contact: Wash immediately and continuously with flowing water for at least 30 minutes. Remove
contact lenses after the first 5 minutes and continue washing. Obtain prompt medical consultation,
preferably from an ophthalmologist. Suitable emergency eye wash facility should be immediately
available.
Ingestion: No emergency medical treatment necessary.
4.2 Most important symptoms and effects, both acute and delayed:
Aside from the information found under Description of first aid measures (above) and Indication of
immediate medical attention and special treatment needed (below), any additional important
symptoms and effects are described in Section 11: Toxicology Information.
4.3 Indication of any immediate medical attention and special treatment needed